Deka Bank Deutsche Girozentrale Gossamer Bio, Inc. Transaction History

Deka Bank Deutsche Girozentrale

  • $54.1 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 02, 2022
BUY
$7.21 - $14.88 $459,277 - $947,856
63,700 Added 390.8%
80,000 $916,000
Q1 2022

Apr 28, 2022
BUY
$8.44 - $12.49 $12,660 - $18,735
1,500 Added 10.14%
16,300 $145,000
Q4 2021

Feb 02, 2022
BUY
$10.12 - $14.07 $4,047 - $5,628
400 Added 2.78%
14,800 $157,000
Q3 2020

Oct 29, 2020
BUY
$11.3 - $14.75 $162,720 - $212,400
14,400 New
14,400 $181,000

Others Institutions Holding GOSS

# of Institutions
108
Shares Held
167M
Call Options Held
430K
Put Options Held
519K
View Full List

About Gossamer Bio, Inc.

GOSS Quotes by TradingView
  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $93M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email